Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?

about

Decision modeling in donation after circulatory death liver transplantation.Can donors with high donor risk indices be used cost-effectively in liver transplantation in US Transplant Centers?

P2860

Q48114326-6340B400-27AE-4CDD-8CA1-895D452D25D5 Q54776566-C4A942FD-A35E-4789-BB89-BC6B6F9B75F4

P2860

Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?

Item

http://www.wikidata.org/entity/Q36609355

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Is liver transplantation using ...... by increasing recipient death?

@ast

Is liver transplantation using ...... by increasing recipient death?

@en

type

Item

label

Is liver transplantation using ...... by increasing recipient death?

@ast

Is liver transplantation using ...... by increasing recipient death?

@en

prefLabel

Is liver transplantation using ...... by increasing recipient death?

@ast

Is liver transplantation using ...... by increasing recipient death?

@en

P1476

Is liver transplantation using ...... by increasing recipient death?

@en

P2093

C Wright Pinson

http://www.w3.org/2001/XMLSchema#string

Derek E Moore

http://www.w3.org/2001/XMLSchema#string

Irene D Feurer

http://www.w3.org/2001/XMLSchema#string

Leigh Anne Dageforde

http://www.w3.org/2001/XMLSchema#string

P2860

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation

Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis.

Survival benefit-based deceased-donor liver allocation

Model for end-stage liver disease (MELD) and allocation of donor livers.

Liver transplantation (1).

Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.

Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.

Decision analysis models: opening the black box.

A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry.

Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?

P304

182-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1477-2574.2012.00524.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23374358

http://www.w3.org/2001/XMLSchema#string

P932

3572278

http://www.w3.org/2001/XMLSchema#string

Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?

about

P2860

P2860

Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932